- Gregory WJ, McNabb PC. Pseudomonas cepacia. Infection Control 1986; 7: 281–4.
- Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206–10.
- Shreve MR, Johnson SJ, Milla CE, Wielinski CL, Regelmann WE. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection. Am J Respir Crit Care Med 1997; 155: 984–9.
- Martone WJ, Tablan OC, Jarvis WR. The epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur J Epidemiol 1987; 3: 222–32.
- Jarvis WR, Olson D, Tablan O, Martone WJ. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987; 3: 233–6.
- Ederer GM, Matsen JM. Colonization and infection with Pseudomonas cepacia. J Infect Dis 1972; 125: 613–8.
- Lu DCT, Chang SC, Chen YC, Luh KT, Lee CY, Hsieh WC. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes. J Formos Med Assoc 1997; 96: 972–8.
- Pegues DA, Carson LA, Anderson RL, Norgard MJ, Argent TA, Jarvis WR, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis 1993; 16: 407–11.
- Rutala WA, Weber DJ, Thomann CA, John JF, Saviteer SM, Sarubbi FA. An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. J Thoracic Cardiovasc Surg 1988; 96: 157–61.
- Lu DCT, Chang SC, Chen YC, Luh KT, Hsish WH. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood. Diagn Microbial Infect Dis 1997; 28: 187–91.
- Bhakta DR, Leader I, Jacobson R, Robinson-Dunn B, Honicky RE, Kumar A. Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan. Chemotherapy 1992; 38: 319–23.
- Leonard A. Mermel: infections related to intravascular devices. In: Olmsted RN, editor. APIC infection control and applied epidemiology: principles and practice. Association for Professionals in Infection Control and Epidemiology, Inc. Missouri: Mosby-Year Book, 1996.
- Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter related infections. N Engl J Med 1977; 296: 1305–19.
- Knaus WA, Draper EA, Wanger DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29.
- Gilligan PH. Pseudomonas and Burkholderia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors Manual of clinical microbiology, 6th edn. Washington, DC: American Society for Microbiology, 1995: 509–19.
- Gray LD. Escherichia, Salmonella, Shigella, and Yersinia. In: Murrar PR, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 6th edn. Washington, DC: American Society for Microbiology, 1995: 450–6.
- National Committee for Clinical Laboratory Standards. Approved standard M2-A5. Performance standards for antimicrobial disk susceptibility tests. 5th edn. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
- Liu PYF, Shi ZY, Lau YJ, Hu BS, Shyr JM, Tsai WS, et al. Molecular analysis of Burkholderia (Pseudomonas) cepacia: differentiation between relapse and reinfection in a case of recurrent bacteremia. Clin Infect Dis 1996; 22: 584–6.
Scandinavian Journal of Infectious Diseases
Volume 31, 1999 - Issue 3